Nonprofit · EIN 06-1504413
THE MULTIPLE MYELOMA RESEARCH FOUNDATION INC
Tax-exempt · NORWALK, CT 06851
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2025 | 990 | $36,523,356 | $34,651,131 | $1,872,225 | $62,872,951 | $14,844,396 | $48,028,555 |
| December 31, 2024 | 990 | $29,101,414 | $35,604,337 | -$6,502,923 | $66,397,148 | $16,374,755 | $50,022,393 |
| December 31, 2023 | 990 | $33,950,590 | $41,890,829 | -$7,940,239 | $80,227,632 | $23,942,208 | $56,285,424 |
Financial details: 990 for the year ended December 31, 2025
Revenue
- Contributions, gifts and grants
- $26,628,081
- Program service revenue
- $8,674,361
- Investment income
- $1,150,050
- Royalties
- $70,864
- Net gain from sales of assets
- -$11,979
- Other revenue
- $70,864
Expenses
- Grants and similar amounts paid
- $3,576,906
- Compensation of officers, directors and key employees
- $3,189,740
- Other salaries and wages
- $7,259,171
- Salaries, compensation and benefits (total)
- $12,331,616
- Professional fundraising fees
- $0
- Legal fees
- $122,586
- Accounting fees
- $63,798
- Occupancy
- $179,428
- Travel
- $668,993
- Depreciation
- $573,594
- Program services (functional)
- $27,353,091
- Management and general (functional)
- $1,191,036
- Fundraising (functional)
- $6,107,004
Balance sheet and other
- Total assets, start of year
- $66,397,148
- Total assets, end of year
- $62,872,951
- Total liabilities, end of year
- $14,844,396
- Net assets, end of year
- $48,028,555
- Land, buildings and equipment
- $673,459
- Publicly traded securities
- $17,683,741
- Net assets without donor restrictions
- $44,811,053
- Net assets with donor restrictions
- $3,217,502
- Gross receipts
- $120,070,404
- Employees
- 80
- Volunteers
- 200
- Year formed
- 1998
- State of legal domicile
- CT
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| MICHAEL ANDREINI | PRESIDENT & CEO Officer | 40 | $534,635 | $33,775 |
| GEORGE MULLIGAN | CHIEF SCIENTIFIC OFFICER Key employee | 40 | $370,521 | $64,920 |
| STEPHANIE OESTREICH | MANAGING DIRECTOR, MIF Key employee | 40 | $397,759 | $33,610 |
| ANNE QUINN YOUNG | CHIEF MISSION OFFICER Key employee | 40 | $374,586 | $19,455 |
| KAREN DIETZ | SECRETARY, CAO & GENERAL COUNSEL Officer | 40 | $287,214 | $48,042 |
| KATIE WOZNIAK | VP OF CLINICAL RESEARCH Key employee | 40 | $244,190 | $58,555 |
| GREG RUBENSTEIN | VP OF MARKETING Highest-paid employee | 40 | $220,914 | $61,822 |
| ASHLEY BLANCHARD | SR DIRECTOR, STRATEGIC PARTNERSHIPS Highest-paid employee | 40 | $189,544 | $57,601 |
| PAM SPEER LEWIS | VP OF DEVELOPMENT Key employee | 40 | $224,834 | $19,800 |
| ALAN HEITNER | TREASURER & CFO Officer | 40 | $230,505 | $10,706 |
| BRIAN HOCHBERG | PRINCIPAL GIFT OFFICER Highest-paid employee | 40 | $184,995 | $55,905 |
| HEARN CHO | CHIEF MEDICAL OFFICER Key employee | 32 | $227,552 | $9,080 |
| JOANNE PUGLIA | SR DIRECTOR FINANCE, CONTROLLER Highest-paid employee | 40 | $199,809 | $12,143 |
| FRANCESCA LAROSA | SR DIRECTOR, HUMAN RESOURCES Highest-paid employee | 40 | $183,151 | $26,736 |
| KATHY GIUSTI | FOUNDER & DIRECTOR Trustee or director | 2 | $0 | $0 |
14 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| THOMAS CONHEENEY | CHAIRMAN Trustee or director, Officer | 2 | $0 |
| GERALD MCDOUGALL | VICE CHAIRMAN Trustee or director, Officer | 2 | $0 |
| KENNETH ANDERSON MD | DIRECTOR Trustee or director | 2 | $0 |
| KAREN ANDREWS | DIRECTOR Trustee or director | 2 | $0 |
| RODNEY GILMORE | DIRECTOR Trustee or director | 2 | $0 |
| DAVID LUCCHINO | DIRECTOR Trustee or director | 2 | $0 |
| LORI TAUBER-MARCUS | DIRECTOR Trustee or director | 2 | $0 |
| HUGH MARTIN | DIRECTOR Trustee or director | 2 | $0 |
| WILLIAM MCKIERNAN | DIRECTOR Trustee or director | 2 | $0 |
| DAVID PARKINSON MD | DIRECTOR Trustee or director | 2 | $0 |
| MARIE PINIZZOTTO MD | DIRECTOR THRU 12/31/2025 Trustee or director | 2 | $0 |
| ADRIAN ROSENKRANZ | DIRECTOR Trustee or director | 2 | $0 |
| STEVE SHAK MD | DIRECTOR Trustee or director | 2 | $0 |
| KIMBERLY WHITE | DIRECTOR Trustee or director | 2 | $0 |
990 for the year ended December 31, 2024: 32 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| MICHAEL ANDREINI | PRESIDENT & CEO Officer | 40 | $466,042 | $26,280 |
| GEORGE MULLIGAN | CHIEF SCIENTIFIC OFFICER Key employee | 40 | $342,276 | $45,540 |
| STEPHANIE OESTREICH | MANAGING DIRECTOR, MIF Key employee | 40 | $337,767 | $26,864 |
| ANNE QUINN YOUNG | CHIEF MISSION OFFICER Key employee | 40 | $335,322 | $18,535 |
| ROBERT MIANI | TREASURER & CFO, THRU JUNE 2024 Officer | 40 | $328,624 | $13,291 |
| KAREN DIETZ | SECRETARY, CAO & GENERAL COUNSEL Officer | 40 | $259,764 | $37,953 |
| MARK HAMILTON | ASSOCIATE DIRECTOR, RESEARCH Highest-paid employee | 40 | $244,473 | $12,496 |
| KATIE WOZNIAK | VP OF CLINICAL RESEARCH Key employee | 40 | $218,889 | $37,919 |
| CHRISTOPHER WILLIAMS | VP OF ALLIANCE MANAGEMENT Key employee | 40 | $218,145 | $36,828 |
| GREG RUBENSTEIN | VP OF MARKETING Highest-paid employee | 40 | $210,723 | $39,864 |
| BRIAN HOCHBERG | PRINCIPAL GIFT OFFICER Highest-paid employee | 40 | $177,081 | $35,811 |
| HEARN CHO | CHIEF MEDICAL OFFICER Key employee | 32 | $204,200 | $8,168 |
| JOANNE PUGLIA | SR DIRECTOR FINANCE, CONTROLLER Highest-paid employee | 40 | $197,545 | $9,187 |
| HEATHER STEIGER | SR DIRECTOR DIGITAL MARKETING Highest-paid employee | 40 | $175,571 | $24,207 |
| ALAN HEITNER | TREASURER & CFO, AS OF OCT. 2024 Officer | 40 | $46,379 | $1,852 |
| KATHY GIUSTI | FOUNDER & DIRECTOR Trustee or director | 2 | $0 | $0 |
| THOMAS CONHEENEY | CHAIRMAN Trustee or director, Officer | 2 | $0 | $0 |
| GERALD MCDOUGALL | VICE CHAIRMAN Trustee or director, Officer | 2 | $0 | $0 |
| KENNETH ANDERSON MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| KAREN ANDREWS | DIRECTOR Trustee or director | 2 | $0 | $0 |
| RODNEY GILMORE | DIRECTOR Trustee or director | 2 | $0 | $0 |
| DAVID LUCCHINO | DIRECTOR Trustee or director | 2 | $0 | $0 |
| LORI TAUBER-MARCUS | DIRECTOR Trustee or director | 2 | $0 | $0 |
| HUGH MARTIN | DIRECTOR Trustee or director | 2 | $0 | $0 |
| SUSAN MARVIN | DIRECTOR Trustee or director | 2 | $0 | $0 |
| WILLIAM MCKIERNAN | DIRECTOR Trustee or director | 2 | $0 | $0 |
| MICHAEL MORTIMER | DIRECTOR Trustee or director | 2 | $0 | $0 |
| DAVID PARKINSON MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| MARIE PINIZZOTTO MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| ADRIAN ROSENKRANZ | DIRECTOR Trustee or director | 2 | $0 | $0 |
| STEVE SHAK MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| KIMBERLY WHITE | DIRECTOR Trustee or director | 2 | $0 | $0 |
990 for the year ended December 31, 2023: 33 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| MICHAEL ANDREINI | PRESIDENT & CEO Officer | 40 | $527,575 | $24,958 |
| ROBERT MIANI | TREASURER & CFO Officer | 40 | $385,910 | $28,032 |
| GEORGE MULLIGAN | CHIEF SCIENTIFIC OFFICER Key employee | 40 | $358,470 | $39,082 |
| ANNE QUINN YOUNG | CHIEF MISSION OFFICER Key employee | 40 | $368,426 | $23,135 |
| KAREN DIETZ | SECRETARY, CAO & GENERAL COUNSEL Officer | 40 | $280,128 | $35,695 |
| CHRISTOPHER WILLIAMS | VP OF ALLIANCE MANAGEMENT Key employee | 40 | $237,539 | $31,093 |
| PETER KOSA | MIF MANAGING DIR., THRU MAY 2023 Key employee | 40 | $247,225 | $15,580 |
| GREG RUBENSTEIN | VP OF MARKETING Highest-paid employee | 40 | $218,085 | $32,026 |
| KATIE WOZNIAK | VP OF CLINICAL RESEARCH Key employee | 40 | $210,845 | $29,597 |
| EVA M LEPISTO | VP OF INFORMATICS Key employee | 40 | $225,272 | $10,378 |
| HEARN CHO | CHIEF MEDICAL OFFICER Key employee | 32 | $223,354 | $8,934 |
| CHARLES VOLPE | DIRECTOR, PR & COMM., THRU DEC. 2023 Highest-paid employee | 40 | $204,169 | $23,980 |
| TODD BROOKS | SR PRINCIPAL GIFT OFFICER Highest-paid employee | 40 | $200,866 | $9,243 |
| JOANNE PUGLIA | SR DIRECTOR FINANCE, CONTROLLER Highest-paid employee | 40 | $195,754 | $10,193 |
| MARK HAMILTON | ASSOCIATE DIRECTOR, RESEARCH Highest-paid employee | 40 | $187,297 | $12,462 |
| MINDY FLINN | VP OF DEVELOPMENT, THRU SEPT. 2023 Key employee | 40 | $166,712 | $19,369 |
| KATHY GIUSTI | FOUNDER & DIRECTOR Trustee or director | 20 | $183,333 | $0 |
| THOMAS CONHEENEY | CHAIRMAN Trustee or director, Officer | 2 | $0 | $0 |
| GERALD MCDOUGALL | VICE CHAIRMAN Trustee or director, Officer | 2 | $0 | $0 |
| KENNETH ANDERSON MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| KAREN ANDREWS | DIRECTOR Trustee or director | 2 | $0 | $0 |
| RODNEY GILMORE | DIRECTOR Trustee or director | 2 | $0 | $0 |
| DAVID LUCCHINO | DIRECTOR Trustee or director | 2 | $0 | $0 |
| LORI TAUBER-MARCUS | DIRECTOR Trustee or director | 2 | $0 | $0 |
| HUGH MARTIN | DIRECTOR Trustee or director | 2 | $0 | $0 |
| SUSAN MARVIN | DIRECTOR Trustee or director | 2 | $0 | $0 |
| WILLIAM MCKIERNAN | DIRECTOR Trustee or director | 2 | $0 | $0 |
| MICHAEL MORTIMER | DIRECTOR Trustee or director | 2 | $0 | $0 |
| DAVID PARKINSON MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| MARIE PINIZZOTTO MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| ADRIAN ROSENKRANZ | DIRECTOR Trustee or director | 2 | $0 | $0 |
| STEVE SHAK MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| KIMBERLY WHITE | DIRECTOR Trustee or director | 2 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 383 MAIN AVE STE 7, NORWALK, CT 06851-1544
- Mailing address (990-N for 2013)
- 1105 Wilson, Richland WA 99354
- Principal officer (990 for 2025)
- MICHAEL ANDREINI, 383 MAIN AVENUE 7TH FL, NORWALK, CT 06851
- Principal officer (990-N for 2013)
- Jessica Parnell, 1925 Lassen Ave, Richland WA 99354
- Signed the 990
- MICHAEL ANDREINI, PRESIDENT & CEO
- Phone
- (203) 229-0464
- Website
- www.parnellgolfclassic.com
- Return prepared by
- PKF O'CONNOR DAVIES ADVISORY LLC
Mission
SEE SCHEDULE O
Program accomplishments
- THE MULTIPLE MYELOMA RESEARCH CONSORTIUM (MMRC), THE CLINICAL RESEARCH SUBSIDIARY OF THE MULTIPLE MYELOMA RESEARCH FOUNDATION (MMRF), IS A COLLABORATIVE NETWORK OF LEADING CANCER CENTERS DRIVING CUTTING-EDGE CLINICAL TRIALS. THE MMRF LAUNCHED THE HORIZON CLINICAL TRIALS PROGRAM THROUGH THE MMRC TO DRIVE PROGRESS FOR PATIENTS WHO NEED IT MOST. HORIZON TRIALS USE AN ADAPTIVE PLATFORM DESIGN THAT ALLOWS RESEARCHERS TO TEST SEVERAL TREATMENTS AT THE SAME TIME AND ADD NEW OPTIONS AS DATA BECOMES AVAILABLE. IN 2025, THE HORIZON ONE TRIAL FOCUSED ON RELAPSED/REFRACTORY MYELOMA EXCEEDED MANY OF ITS ENROLLMENT GOALS FOR ITS FIRST TREATMENT ARM, WHICH IS TESTING DOSING APPROACHES FOR A BISPECIFIC ANTIBODY. THE TRIAL SO FAR HAS ENROLLED MORE BLACK PATIENTS AND OLDER ADULTSTWO GROUPS THAT HAVE HISTORICALLY BEEN LEFT OUT OF RESEARCHTHAN MOST MYELOMA TRIALS. HORIZON ONE BECAME THE FIRST-EVER MYELOMA CLINICAL TRIAL IN FLINT, MICHIGAN, AND IT OPENED AT 25 COMMUNITY HOSPITALS AND CLINICS LAST YEAR. ALSO IN 2025, 13 SITES ENTERED THE START-UP PHASE IN THE HORIZON TWO CLINICAL TRIAL FOCUSED ON HIGH-RISK, NEWLY DIAGNOSED MYELOMA SO THEY COULD FULLY OPEN AND BEGIN SCREENING PATIENTS IN 2026.Expenses $6,096,220 · revenue $8,674,361
- DATA HELPS DRIVE EVERY BREAKTHROUGH IN MYELOMA. BY BUILDING AND SHARING LARGE, HIGH-QUALITY DATASETS, THE MMRF IS CREATING A LAUNCHPAD FOR THE NEXT WAVE OF TREATMENTS, IMPROVEMENTS IN CARE, AND, ULTIMATELY, CURES. IN 2025, THE MMRF LAUNCHED ITS NEXT INNOVATION IN DATA SHARING: THE MMRF VIRTUAL LABTM. VIRTUAL LAB IS NOW MYELOMA'S LARGEST, MOST-COMPREHENSIVE DATA-SHARING PLATFORM AND BRINGS ALL THE MMRF'S DATA INTO ONE PLACE. THE PLATFORM AND ITS ROBUST DATA WILL EMPOWER RESEARCHERS TO ASK BIGGER QUESTIONS, TEST NEW HYPOTHESES, AND ACCELERATE DISCOVERIES THAT IMPROVE OUTCOMES FOR PATIENTS WITH MYELOMA.Expenses $2,669,588
- THE MAC PROGRAM PROVIDES $21 MILLION OVER 3 YEARS TO CREATE MULTICENTER TRANSLATIONAL RESEARCH TEAMS ACROSS GLOBAL MEDICAL CENTERS. EACH OF THESE THREE-YEAR MULTICENTER TRANSLATIONAL PROJECTS AIM TO FOSTER COLLABORATION AND ADVANCE COMPELLING HYPOTHESES THAT ARE READY FOR RAPID TESTING IN CLINICAL TRIALS, A CRITICAL STEP IN THE MMRF'S URGENT PURSUIT OF A CURE FOR EACH AND EVERY MYELOMA PATIENT. THE GRANTS ARE FOCUSED ON TWO CRITICAL AREAS OF UNMET NEED: OPTIMIZING FIRST-LINE THERAPY FOR NEWLY DIAGNOSED HIGH-RISK MYELOMA AND IMPROVING IDENTIFICATION OF HIGH-RISK SMOLDERING MYELOMA (HR SMM), AN EARLY, ASYMPTOMATIC STAGE THAT CAN PROCEED TO ACTIVE MYELOMA. IN 2025 THE COLLABORATING CENTERS CONTINUED TO MAKE POSITIVE PROGRESS, SHOWING THAT POOLING RESOURCES AND SAMPLES ACROSS A NETWORK OF INSTITUTIONS DRAMATICALLY IMPROVES THE ABILITY TO DRIVE MEANINGFUL RESULTS.Expenses $1,600,000
- BEYOND THE PROGRAM EXPENSES OUTLINED ABOVE, THE MMRF ALSO SUPPORTS A RANGE OF STRATEGIC INITIATIVES ALIGNED WITH ITS BROADER MISSION. THIS INCLUDES A ROBUST PORTFOLIO OF CUTTING-EDGE BASIC SCIENCE AND TRANSLATIONAL RESEARCH AIMED AT IDENTIFYING NEW THERAPEUTIC TARGETS THROUGH GENOMICS AND PROTEOMICS; VALIDATION STUDIES TO EXPLORE PROMISING COMPOUNDS AND TREATMENT COMBINATIONS; AND INNOVATIVE CLINICAL TRIALS FOCUSED ON NOVEL AND COMBINATION THERAPIES.FOUNDED BY PATIENTS, THE MMRF IS DEEPLY COMMITTED TO THOSE IMPACTED BY MYELOMA: PATIENTS, FAMILIES, PHYSICIANS, RESEARCHERS, AND INVESTORS. AT THE SAME TIME, THE MMRF DISTINGUISHES ITSELF THROUGH ITS BOLD AND COLLABORATIVE APPROACH. WE GENERATE, ANALYZE, AND SHARE THE LARGEST, MOST COMPREHENSIVE SET OF HIGH-QUALITY MYELOMA DATA, MAKING IT PUBLICLY AVAILABLE TO ACCELERATE PROGRESS. BY BRINGING TOGETHER THE RIGHT PEOPLE, PROGRAMS, AND TECHNOLOGIES, THE MMRF IS DRIVING THE RAPID DISCOVERY OF CURES FOR EACH AND EVERY PATIENT.Expenses $16,987,283 · grants $3,576,906 · revenue $70,864
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | 990 on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 06-1504413
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1998
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Voluntary health associations and medical disciplines (G50)
- Assets (IRS master file)
- $62,872,951
- Income (IRS master file)
- $120,070,404
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2025 | $36,523,356 | $34,651,131 | $62,872,951 | XML |
| 990 | December 2024 | $29,101,414 | $35,604,337 | $66,397,148 | XML |
| 990 | December 2023 | $33,950,590 | $41,890,829 | $80,227,632 | XML |
| 990 | December 2022 | $45,044,474 | $38,280,730 | $89,097,661 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
| 990 | December 2017 | – | – | – | IRS |
| 990-N for 2013 Officer: Jessica Parnell | December 31, 2013 | ≤ $50,000 receipts | – | – | e-Postcard |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 06-1504413).
Questions about THE MULTIPLE MYELOMA RESEARCH FOUNDATION INC
- What is the EIN of THE MULTIPLE MYELOMA RESEARCH FOUNDATION INC?
- The employer identification number (EIN) of THE MULTIPLE MYELOMA RESEARCH FOUNDATION INC is 06-1504413.
- Is THE MULTIPLE MYELOMA RESEARCH FOUNDATION INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1998.
- Are donations to THE MULTIPLE MYELOMA RESEARCH FOUNDATION INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does THE MULTIPLE MYELOMA RESEARCH FOUNDATION INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of THE MULTIPLE MYELOMA RESEARCH FOUNDATION INC due?
- The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did THE MULTIPLE MYELOMA RESEARCH FOUNDATION INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2025.
- Who is the principal officer of THE MULTIPLE MYELOMA RESEARCH FOUNDATION INC?
- The 990 for the year ended December 31, 2025 names MICHAEL ANDREINI.
- Who are the officers and directors of THE MULTIPLE MYELOMA RESEARCH FOUNDATION INC?
- The 990 for the year ended December 31, 2025 lists 29 people; 14 received compensation from the organization, the highest $534,635 (MICHAEL ANDREINI, PRESIDENT & CEO).
- How much revenue does THE MULTIPLE MYELOMA RESEARCH FOUNDATION INC have?
- On its 990 for the year ended December 31, 2025 it reported revenue of $36,523,356, expenses of $34,651,131 and total assets of $62,872,951 at year end.
Other nonprofits in NORWALK
- CACNA1A FOUNDATION INC EIN 84-4985747 · last filed 990 for 2025
- TICKED OFF FOUNDATION INC EIN 47-4783824 · last filed 990-N for 2025
- RETRAINTOWALK INC EIN 82-4614079 · last filed 990-N for 2025
- GENERAL ELECTRIC COMPANY INSURANCE PLAN TRUST CO V A DIAMANTE EIN 51-0169382 · last filed 990 for 2024
- NORWALK HOSPITAL ASSOCIATION EIN 06-6068853 · last filed 990 for 2025
- FINANCIAL ACCOUNTING FOUNDATION EIN 23-7211935 · last filed 990 for 2025
- NORWALK HOSPITAL FOUNDATION INC EIN 22-2577707 · last filed 990 for 2025
- FAIRFIELD COUNTYS COMMUNITY FOUNDATION INC EIN 06-1083893 · last filed 990 for 2025
All nonprofits in NORWALK · Connecticut · Voluntary health associations and medical disciplines